71
CDC and FDA recommend US pause use of Johnson & Johnson's Covid-19 vaccine over blood clot concerns
deleted.comThe US Centers for Disease Control and Prevention and the US Food and Drug Administration are recommending that the United States pause the use of Johnson & Johnson's Covid-19 vaccine over six reported US cases of a "rare and severe" type of blood clot. The six reported cases were among more than 6.8 million doses of the Johnson & Johnson vaccine administered in the United States. All six cases occurred among women ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination, according to a joint statement on Tuesday from Dr. Anne Schuchat, principal deputy director of the CDC and Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research.
Permanently Deleted
I just read that Gao Fu, the director of the Chinese Center for Disease Control and Prevention, just came out saying that their vaccines have a lower success rate of somewhere in the ballpark of 50-70 percent effectiveness and that they need to go back to the drawing board in order to improve their vaccines.
Of course this just drives another nail into America's coffin, since it proves the PRC definitely stopped the spread of the virus through thorough coordination of the people and the state and not through relying on medical science to save the day after letting the plague rampage for a while.
Why would this be a nail in America's coffin? The situation is ripe for the US to replace China when it comes to vaccine diplomacy. That's a geopolitical victory for the US, no?
No. The U.S has at large focused on itself first and foremost as it's allowed itself to become the most impacted nation by the pandemic thus far. It hardly produces the medical tech and equipment it needs as it outsourced it's industry to cheaper countries, like China. Additionally, capitalists holds the vaccine formulas hostage in exchange for an exorbitant cost. Poor countries would have to sell themselves once again into bondage just tiny shipments of the vaccine should they not be lucky enough to purchase the license to produce it.
Contrasted with China's efforts to mass-produce medical supplies for global usage and the vaccines that have been made by them is already being distributed globally as well. Their efficiency has simply slid them from providing viral immunity to being viral prophylactics, which helps slow down the spread of the virus significantly from it's previously unchecked pace.
This is still weighted heavily in China's favor from my perspective.